top of page
Search Results
All (281)
Products (8)
Events (206)
Blog Posts (8)
Other Pages (59)
206 results found with an empty search
- NeuroSense Therapeutics Reports Positive Results from Stage III ALS Biomarker StudyAugust 4, 2022 | 2:00 AM
- How do we track ALS progression, and why does it matterJuly 20, 2022 | 11:00 PM
- Technology for ALS Living and Voice BankingJuly 6, 2022 | 11:00 PM
- Findings from EverythingALS StudiesJune 22, 2022 | 11:00 PM
- ALS - Unmet NeedsJune 8, 2022 | 11:00 PM
- Moving from a few genes to a genetic architecture for ALS and the insights it providesMay 11, 2022 | 11:00 PM
- Augmentative communications program for ALSApril 27, 2022 | 11:00 PM
- New Gene Therapy for ALSApril 13, 2022 | 11:00 PM
- Antisense Oligonucleotide Therapy for ALSMarch 30, 2022 | 11:00 PM
- Thoughts On Clinical Trials From the perspectives of an ALS Center DirectorMarch 3, 2022 | 12:00 AM
- Expanded Access for Rare DiseasesFebruary 3, 2022 | 12:00 AM
_edited.png)
bottom of page